United States Respiratory Devices Market Size (2024 - 2029)

The United States respiratory devices market is anticipated to experience growth due to increased demand driven by the prevalence of respiratory conditions such as COPD, asthma, and pneumonia, as well as the impact of the COVID-19 pandemic. The market's expansion is supported by strategic government initiatives and product launches by key players, addressing the heightened need for devices like ventilators and nebulizers. Despite these growth drivers, the high cost of respiratory devices may pose a challenge to market expansion.

Market Size of United States Respiratory Devices Industry

USA Respiratory Devices Market Size
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR 6.20 %
Market Concentration Low

Major Players

United States Respiratory Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

USA Respiratory Devices Market Analysis

United States Respiratory Devices Market is poised to grow at a CAGR of 6.2% over the forecast period (2022-2027).

Major respiratory devices, including ventilators, nebulizers, CPAP, BiPAP, and oxygen concentrators, are in great demand because they are commonly utilized for COVID-19 patients. With the rising severity of COVID-19 in major countries such as the United States, the Vesper device developed by Prisma Health was granted emergency use permitted by the United States Food and Drug Administration (FDA) in March 2020 to help with ventilator shortages. In addition, the United States government has implemented several strategic projects during the COVID-19 pandemic to fulfil respiratory device demand. For instance, in April 2020, Philips and the United States government worked to enhance hospital ventilator output. Similarly, as per the updates in May 2021 by the American Association of Respiratory Care, the stockpile of mechanical ventilators has been expanded by the Office of the Assistant Secretary for Preparedness and Response (ASPR). This demonstrates the critical need for breathing devices such as ventilators in the nations affected by COVID-19. As a result, the COVID-19 pandemic has had a favourable impact on the market analysed.

The rise in the number of chronic obstructive pulmonary disease patients (COPD), TB, asthma, and pneumonia cases remains the major driver of the industry. As per the April 2021 statistics by the Asthma and Allergy Foundation of America, each year, over 20 million persons in the United States aged 18 and above suffer from asthma. Thus, the frequency of such conditions in the country implies a steady need for respiratory devices in the country, leading to the expansion of the market examined in the United States. In addition, according to the study titled "Respiratory Symptoms among US Adults: a Cross-Sectional Health Survey Study" published in the Pulmonary Therapy in July 2022, the most common respiratory symptom, followed by a productive cough and shortness of breath, affects 17% of adult Americans. Thus, with the growing burden of respiratory diseases, the demand for respiratory devices is expected to increase over the forecast period, thereby boosting market growth.

Moreover, growing product launches by key market players support the market expansion over the forecast period. For instance, in May 2022, Honeywell launched NIOSH-certified respiratory DC365 Small Surgical N95 Respirator products to help healthcare personnel fulfil their demands. Thus, all the above-mentioned factors are expected to boost market growth over the forecast period. However, the high cost of respiratory devices may restrain the market growth.

USA Respiratory Devices Industry Segmentation

As per the scope of the report, Respiratory devices include respiratory diagnostic and monitoring devices, therapeutic devices, and disposables for administering long-term artificial respiration. The United States Respiratory Devices Market is segmented By Type (Diagnostic and Monitoring Devices (Spirometers, Sleep Test Devices, Peak Flow Meters, Pulse Oximeters, Capnographs, Other Diagnostic and Monitoring Devices), Therapeutic Devices (CPAP Devices, BiPAP Devices, Humidifiers, Nebulizers, Oxygen Concentrators, Ventilators, Inhalers, Other Therapeutic Devices), and Disposables (Masks, Breathing Circuits, Other Disposables). The report offers the value (in USD million) for the above segments.

By Type
By Diagnostic and Monitoring Devices
Spirometers
Sleep Test Devices
Peak Flow Meters
Pulse Oximeters
Capnographs
Other Diagnostic and Monitoring Devices
By Therapeutic Devices
CPAP Devices
BiPAP Devices
Humidifiers
Nebulizers
Oxygen Concentrators
Ventilators
Inhalers
Other Therapeutic Devices
By Disposables
Masks
Breathing Circuits
Other Disposables
Need A Different Region Or Segment?
Customize Now

United States Respiratory Devices Market Size Summary

The United States respiratory devices market is experiencing significant growth, driven by the increased demand for essential equipment such as ventilators, nebulizers, CPAP, BiPAP, and oxygen concentrators. This surge in demand is largely attributed to the COVID-19 pandemic, which highlighted the critical need for these devices to support patients with respiratory challenges. The pandemic prompted swift actions from both the government and private sector, including emergency use authorizations and strategic partnerships to boost production and stockpiles of ventilators. The ongoing prevalence of respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, and pneumonia further fuels the market's expansion, as these conditions necessitate the use of respiratory devices for effective management and treatment.

The market is characterized by a moderate level of competition, with several global players dominating the landscape. Companies like Chart Industries Inc., Dragerwerk AG, and Koninklijke Philips N.V. are key contributors to the market's growth through continuous product innovations and strategic collaborations. Recent developments, such as the launch of advanced ventilators and digital health solutions, underscore the industry's commitment to enhancing respiratory care. Despite the promising growth trajectory, the high cost of respiratory devices poses a potential challenge to market expansion. Nonetheless, the combination of rising disease prevalence, technological advancements, and strategic industry initiatives is expected to sustain the market's growth over the forecast period.

Explore More

United States Respiratory Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Prevalence of Respiratory Disorders

      2. 1.2.2 Technological Advancements

      3. 1.2.3 Increasing Application in Homecare Setting

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Respiratory Device

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value USD million)

    1. 2.1 By Type

      1. 2.1.1 By Diagnostic and Monitoring Devices

        1. 2.1.1.1 Spirometers

        2. 2.1.1.2 Sleep Test Devices

        3. 2.1.1.3 Peak Flow Meters

        4. 2.1.1.4 Pulse Oximeters

        5. 2.1.1.5 Capnographs

        6. 2.1.1.6 Other Diagnostic and Monitoring Devices

      2. 2.1.2 By Therapeutic Devices

        1. 2.1.2.1 CPAP Devices

        2. 2.1.2.2 BiPAP Devices

        3. 2.1.2.3 Humidifiers

        4. 2.1.2.4 Nebulizers

        5. 2.1.2.5 Oxygen Concentrators

        6. 2.1.2.6 Ventilators

        7. 2.1.2.7 Inhalers

        8. 2.1.2.8 Other Therapeutic Devices

      3. 2.1.3 By Disposables

        1. 2.1.3.1 Masks

        2. 2.1.3.2 Breathing Circuits

        3. 2.1.3.3 Other Disposables

United States Respiratory Devices Market Size FAQs

The United States Respiratory Devices Market is projected to register a CAGR of 6.20% during the forecast period (2024-2029)

Dragerwerk AG, Fisher & Paykel Healthcare Limited, GE Healthcare, Koninklijke Philips NV and GlaxoSmithKline PLC are the major companies operating in the United States Respiratory Devices Market.

United States Respiratory Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)